Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong
· Delayed Price · Currency is HKD 1.400
+0.060 (4.48%)
At close: Mar 10, 2026
HKG:0950 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 824 | 836 | 901 | 960 | 1,961 | 2,764 | Upgrade
|
| Market Cap Growth | 12.90% | -7.19% | -6.13% | -51.05% | -29.06% | 6.37% | Upgrade
|
| Enterprise Value | 644 | 802 | 864 | 750 | 1,783 | 2,514 | Upgrade
|
| Last Close Price | 1.40 | 1.38 | 1.45 | 1.52 | 3.05 | 4.24 | Upgrade
|
| PE Ratio | 8.43 | 8.98 | 53.95 | 18.72 | 0.99 | 21.38 | Upgrade
|
| Forward PE | - | 8.46 | 10.89 | 8.15 | 10.41 | 12.37 | Upgrade
|
| PS Ratio | 0.57 | 0.60 | 0.86 | 0.78 | 1.55 | 2.27 | Upgrade
|
| PB Ratio | 0.45 | 0.54 | 0.46 | 0.52 | 0.82 | 1.31 | Upgrade
|
| P/TBV Ratio | 1.19 | 0.63 | 0.51 | 0.59 | 0.91 | 1.49 | Upgrade
|
| P/FCF Ratio | 2.54 | 4.22 | 11.17 | 3.61 | 12.26 | 34.33 | Upgrade
|
| P/OCF Ratio | 2.24 | 3.46 | 8.18 | 3.38 | 9.31 | 12.63 | Upgrade
|
| PEG Ratio | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | Upgrade
|
| EV/Sales Ratio | 0.45 | 0.57 | 0.82 | 0.61 | 1.41 | 2.07 | Upgrade
|
| EV/EBITDA Ratio | 2.77 | 3.64 | 6.62 | 3.15 | 105.94 | 9.64 | Upgrade
|
| EV/EBIT Ratio | 4.89 | 6.01 | 23.98 | 5.89 | - | 16.83 | Upgrade
|
| EV/FCF Ratio | 1.98 | 4.05 | 10.72 | 2.82 | 11.15 | 31.23 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.15 | 0.10 | 0.09 | 0.11 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 1.04 | 0.98 | 1.42 | 0.65 | 8.39 | 0.57 | Upgrade
|
| Debt / FCF Ratio | 0.75 | 1.15 | 2.53 | 0.61 | 1.67 | 1.95 | Upgrade
|
| Net Debt / Equity Ratio | -0.03 | 0.01 | 0.02 | -0.01 | 0.00 | -0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.27 | 0.05 | 0.25 | -0.11 | -0.62 | -0.99 | Upgrade
|
| Net Debt / FCF Ratio | -0.18 | 0.05 | 0.41 | -0.10 | -0.06 | -3.20 | Upgrade
|
| Asset Turnover | 0.52 | 0.51 | 0.37 | 0.38 | 0.37 | 0.35 | Upgrade
|
| Inventory Turnover | 2.64 | 2.21 | 1.83 | 1.59 | 1.23 | 1.30 | Upgrade
|
| Quick Ratio | 0.71 | 0.55 | 0.46 | 0.46 | 0.51 | 0.61 | Upgrade
|
| Current Ratio | 1.06 | 1.02 | 1.01 | 1.00 | 1.04 | 1.31 | Upgrade
|
| Return on Equity (ROE) | 3.73% | 3.91% | 1.05% | 2.17% | 86.98% | 3.42% | Upgrade
|
| Return on Assets (ROA) | 3.00% | 3.03% | 0.79% | 2.48% | -1.73% | 2.71% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.96% | 5.26% | 1.23% | 4.10% | -4.47% | 4.70% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 7.20% | 1.60% | 6.00% | -3.50% | 6.50% | Upgrade
|
| Earnings Yield | 11.86% | 11.13% | 1.85% | 5.34% | 101.34% | 4.68% | Upgrade
|
| FCF Yield | 39.42% | 23.69% | 8.95% | 27.73% | 8.16% | 2.91% | Upgrade
|
| Dividend Yield | 3.51% | 3.26% | 1.24% | 1.31% | 2.00% | 1.37% | Upgrade
|
| Payout Ratio | 27.09% | 18.97% | 63.48% | 47.08% | 1.81% | 29.56% | Upgrade
|
| Buyback Yield / Dilution | - | 0.00% | 0.00% | 0.04% | -0.15% | 0.63% | Upgrade
|
| Total Shareholder Return | 3.41% | 3.26% | 1.24% | 1.35% | 1.85% | 2.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.